MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$212,394K
Interest income
$11,719K
Loss from operations
-$224,113K
Collaboration revenue
$6,941K
Total operating
expenses
$231,054K
Research and development
$177,286K
General and
administrative
$43,768K
In-process research and
development
$10,000K
Back
Back
Income Statement
source: myfinsight.com
Immunome Inc. (IMNM)
Immunome Inc. (IMNM)